<DOC>
	<DOCNO>NCT00002477</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one drug may kill cancer cell . PURPOSE : Randomized phase III trial compare effectiveness adjuvant therapy use platinum-based chemotherapy drug adjuvant therapy treat patient early stage invasive ovarian epithelial cancer .</brief_summary>
	<brief_title>Adjuvant Chemotherapy Compared With Observation Treating Patients With Resected Early Stage Ovarian Epithelial Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Determine whether adjuvant chemotherapy platinum-containing regimen ( e.g. , carboplatin CAP : cyclophosphamide/doxorubicin/cisplatin ) prolongs survival patient early stage ovarian cancer compare receive adjuvant treatment . OUTLINE : Randomized study . Patients randomized Arm I II ; treatment begin within 6 week surgery . Regimens list Arm I recommend , platinum-containing regimen allow provided dos minimum meet list . Arm I : Single-agent Chemotherapy 3-Drug Combination Chemotherapy . Carboplatin , CBDCA , NSC-241240 ; CAP : Cyclophosphamide , CTX , NSC-26271 ; Doxorubicin , DOX , NSC-123127 ; Cisplatin , CDDP , NSC-119875 . Arm II : Observation . No adjuvant therapy . PROJECTED ACCRUAL : A maximum 2,000 patient randomize .</detailed_description>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Liposomal doxorubicin</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm invasive ovarian cancer epithelial origin All tumor resect prior randomization Uncertain whether immediate chemotherapy require PATIENT CHARACTERISTICS : Age : Any age Performance status : Sufficient receive chemotherapy Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Other : No prior malignancy except nonmelanomatous skin cancer No clear contraindication chemotherapy PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior chemotherapy Endocrine therapy : Not specify Radiotherapy : No prior radiotherapy Surgery : Minimum recommend surgical procedure ( possible ) : Thorough surgical staging Total hysterectomy/bilateral salpingooophorectomy Omentectomy , follow : Total supracolonic omentectomy omentum involve Removal distal 2 cm infracolonic omentectomy absence macroscopic disease</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2007</verification_date>
	<keyword>stage I ovarian epithelial cancer</keyword>
	<keyword>stage II ovarian epithelial cancer</keyword>
</DOC>